This study investigates high-risk hematological and solid tumors. It focuses on understanding these conditions through a detailed diagnostic approach.
The purpose of this study is to evaluate the effectiveness of a diagnostic platform that integrates multiple scientific techniques to better understand tumor characteristics.
- Who can participate: Patients aged 1 year and older with a diagnosis of hematological or solid malignancy can participate. Informed consent is required, with guidelines for minors.
- Study details: Participants will provide primary samples for analysis. The study uses an investigational approach to gather diagnostic information.
How understandable was the trial content above?
Hard to understand
Easy to understand